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A retrospective histopathologic review of all patho-
logic specimens from 394 adult liver transplant patients 
was undertaken with clinical correlation to determine 
if primary biliary cirrhosis has affected the posttrans-
plant course compared to all other indications for liver 
transplantation and if recurrent primary biliary cirrho-
sis has occurred after liver transplantation. We also 
compared the histopathologic features seen in native 
livers with primary biliary cirrhosis to failed allografts 
with chronic rejection. One hundred six of the 394 adult 
patients transplanted during this time (1981 to July, 
1986) fulfilled clinicopathologic criteria for a diagnosis 
of primary biliary cirrhosis. Neither the incidence nor 
any qualitative pathologic feature of histologically doc-
umented acute cellular rejection differentiated subjects 
transplanted for primary biliary cirrhosis vs. other dis-
eases. No correlation between the titers of antimitochon-
drial antibody and the presence of posttransplant he-
patic dysfunction based on liver enzyme profiles or the 
development of chronic rejection was seen in patients 
transplanted for primary biliary cirrhosis. Minor dif-
ferences noted in the posttransplant course of primary 
biliary cirrhosis patients as compared to other condi-
tions (higher incidence of chronic rejection as a cause of 
graft failure) was seen, but this did not significantly 
affect graft or patient survival. Recurrent primary bil-
iary cirrhosis could not be diagnosed with certainty in 
any patient. A comparison of failed chronically rejected 
allografts vs. native hepatectomies obtained from pa-
tients with primary biliary cirrhosis revealed the pres-
ence of chronic obliterative vasculopathy, centrilobular 
cholestasis, and lack of granulomas, cirrhosis, cholan-
giolar proliferation, copper-associated protein deposi-
tion and Mallory's hyalin in specimens with chronic 
rejection. In contrast, livers removed from patients with 
primary biliary cirrhosis demonstrated a mild vasculo-
pathy, cirrhosis, granulomas, copper-associated protein 
deposition, Mallory's hyalin and periportal cholestasis. 
Both conditions demonstrated a nonsuppurative de-
structive cholangitis with bile duct paucity. 
Primary biliary cirrhosis (PBC) is a disorder of uncer-
tain etiology that primarily affects middle-aged females 
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and frequently results in chronic cholestatic liver disease. 
There is considerable circumstantial evidence to suggest 
that PBC is an autoimmune disorder. This evidence 
consists of the presence of anti mitochondrial antibodies 
(AMA), in vivo complement activation, a nonsuppurative 
destructive cholangitis which can progress to cirrhosis 
and a variety of systemic manifestations which are also 
seen in graft-vs.-host disease (1-4). A diagnosis of PBC 
depends upon the combination of a consistent clinical, 
serologic and histopathologic profile. No effective medi-
cal therapy for this disorder has been fully established. 
Liver transplantation has become the treatment of 
choice for patients with advanced disease. 
Histopathologic (5-7) and pathophysiologic (8, 9) sim-
ilarities exist between PBC, graft-vs.-host disease and 
liver allograft rejection, particularly "chronic rejection." 
Neuberger et a1. (10) have suggested that recurrent PBC 
occurs in patients transplanted for this indication. This 
conclusion was based on the findings of a consistent 
hepatic histopathology, the presence of AMA and a post-
transplant clinical course consistent with PBC. The doc-
umentation of recurrent disease is of paramount impor-
tance in organ transplantation. The ability to distinguish 
between these two processes (i.e. PBC and chronic liver 
allograft rejection) is essential for recognition of recur-
rent PBC. We undertook the following study to deter-
mine if, using criteria offered by Neuberger et a1., we 
could document recurrent PBC in patients transplanted 
for PBC; to compare the histopathologic features of 
chronic liver allograft rejection and PBC, and to deter-
mine the effect, if any, of the primary disease on the 
posttransplantation course of patients with liver trans-
planted for PBC as compared to that of patients with 
transplantation for other indications. 
MATERIALS AND METHODS 
Source Material. A retrospective histopathologic review 
with clinical correlation of all adult liver specimens obtained 
from patients who underwent orthotopic liver transplantation 
between January, 1981, and July, 1986, at the University of 
Pittsburgh was carried out by a single pathologist (A.J.D.). 
All hepatectomy specimens (native and allograft) were sec-
tioned according to a predefined protocol (11) so that similar 
areas of the liver were studied. All sections were stained with 
hematoxylin and eosin. Selected sections from each case were 
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stained with trichrome and periodic acid-Schiff with diastase 
digestion. One section from 25 primary hepatectomy specimens 
with PBC, a section from all failed allografts because of chronic 
rejection and all posttransplant biopsies from patients with 
PBC as their original disease obtained at any time greater than 
6 months posttransplantation were stained with orcein and/or 
rhodanine for the detection of copper-associated protein and 
copper, respectively. 
Pathologic Features Examined. All posttransplant 
liver pathology specimens were evaluated for histopathologic 
features used in the evaluation of posttransplant liver speci-
mens developed for the National Institute of Diabetes and 
Digestive and Kidney Diseases liver transplant data base (12). 
These criteria include the severity and composition of portal 
inflammation, the presence of subendothelial mononuclear in-
filtration of portal and/or central veins, the presence and 
percentage of damaged bile ducts, ductular and cholangiolar 
proliferation, piecemeal necrosis, lobular inflammation, disar-
ray and hepatocyte necrosis and the presence and location of 
cholestasis. In addition to these features, the native hepatec-
tomy specimens obtained from patients with PBC and failed 
allografts with chronic rejection were evaluated for the presence 
of several other findings. Specific additional features examined 
in these hepatectomy specimens included the approximate size 
of damaged bile ducts, presence of cirrhosis, piecemeal necrosis 
and type, extent and location of copper-associated protein 
deposition and the type and degree of arterial and venous 
pathology. A pretransplant wedge or needle biopsy obtained 
earlier in the course of their disease was available from 15 of 
the 106 patients transplanted for PBe. 
Diagnostic Criteria. The criteria utilized to establish 
the diagnosis of PBC prior to transplantation were the presence 
of AMA (usually in titers greater than 1:40), a consistent 
clinical and biochemical profile (3) and a characteristic hepatic 
histopathology (4). 
The pathologic criteria employed to diagnose hepatic rejec-
tion have been reported previously (11). For acute rejection 
these were the presence of a predominantly mononuclear portal 
inflammatory infiltrate, bile duct epithelial damage such as 
vacuolization, eosinophilia, pyknosis, dysplasia and/or luminal 
disruption and the absence of significant lobular alterations 
suggestive of any alternative diagnosis. Chronic rejection was 
diagnosed when two of the following three criteria (inclusive of 
criterion ii) were present: (i) mononuclear portal tract infiltrate 
(usually mild to moderate); (ii) duct damage in greater than 
50% of the ducts with associated loss of bile ductules, and (iii) 
obliterative vasculopathy similar to that described in other 
solid organ allografts. All of the biopsy samples were obtained 
at the discretion of attending physicians who used clinical and/ 
or biochemical indications of liver dysfunction as an indication 
for liver biopsy. 
Patient Demographic Data. One hundred six of 394 
patients transplanted during this period (1981 to July, 1986) 
satisfied the criteria for the pretransplant diagnosis of PBC 
(average age = 46.2 years; 93 females, 13 males). There were 
209 posttransplant biopsies, 31 failed allografts and 11 autopsy 
specimens available for review in these 106 PBC patients. 
The control samples consisted of all of the histopathologic 
material available on 288 patients, all of whom had a primary 
disease other than PBC and were transplanted during the same 
period of time. The average age of these individuals was 41.0 
years; 123 were females and 162 were males. Significant AMA 
titers were detected in none of these patients. For this group, 
431 biopsies, 74 failed allografts and 31 autopsy specimens were 
available for review. All patients had been maintained on an 
cyclosporin/steroid immunosuppressive regimen after trans-
plantation with individual titration of dosages. 
RESULTS 
Analysis of the Postoperative Course 
Comparison of the Incidence and Histologic Appearance 
of Acute Cellular Rejection: The incidence and patho-
logic appearance of histologically documented episodes 
of acute cellular rejection occurring in PBC patients were 
compared to those seen in all other patients (non-PBC). 
No attempt was made to evaluate histologic features of 
any nonrejection allograft syndromes because it was be-
lieved that recurrent PBC would appear more similar to 
rejection than other graft pathology. No significant dif-
ference in the incidence or qualitative histologic feature 
distinguished between these two groups (Table 1). How-
ever, more of the biopsies obtained from PBC patients 
with acute cellular rejection as the primary diagnosis had 
greater than 50% of the bile ducts damaged and demon-
strated piecemeal necrosis as compared to patients trans-
planted for other indications (p < 0.05). It must be 
emphasized, however, that the presence of piecemeal 
necrosis was based on a subjective interpretation of each 
biopsy and as such may not be either reliable or 
reproducible. 
AMA Serology: The results of the AMA serologic 
screening studies and the clinical course of the first 76 
patients transplanted for PBC after transplantation have 
been reported previously (13). No fractionation of AMA 
subtypes was performed (14). Of these patients 98% had 
elevated AMA titers prior to transplantation. In contrast, 
no significant AMA elevations were present in the pa-
TABLE 1. Comparison of histologic features of post transplant 
pathology specimens with diagnosis of acute cellular rejection 
from patients with PBC and non-PBC prior to transplantation 
x 2 
Non-PBC PBC probability 
(p value) 
Total patients 288 (100) 106 (100) 
No. of patients having at 225 (78) 85 (80) 
least one specimen for 
review 
No. of patients with at 115 (51) 50 (58) 0.30 
least one histologically 
documented episode of 
acute cellular rejection a 
Total No. of specimens 174 (100) 106 (100) 
with ACRb as primary 
diagnosis 
No. of ACR specimens 46 (26) 44 (41) 0.01 
with >50% bile duct 
damage 
No. of ACR specimens 37 (21) 19 (17) 0.60 
with ductular prolifera-
tion 
No. of ACR specimens 5 (3) 5 (5) 0.60 
with arteritis 
No. of ACR specimens 3 (2) 11 (10) <0.01 
with piecemeal necrosis 
Numbers of patients (percentages) are given. 
a Percentage is calculated using patients with pathology specimens 
for review as denominator. 
b ACR = Acute cellular rejection. 
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tients transplanted for a disease other than PBC. Forty-
three of the 45 survivors with PBC had elevated AMA 
titers postoperatively which, in general, remained at the 
same level or decreased slightly in titer following trans-
plantation. There has been no apparent correlation be-
tween the presence of a postoperative elevated AMA titer 
and the presence of any liver dysfunction as assessed 
using standard liver injury parameters (13). 
Two of the 10 patients with PBC as their original 
disease who lost their grafts because of chronic rejection 
experienced a decline in their AMA titers posttransplan-
tation. Two others have shown an increase, and another 
two have had no change. Follow-up titers were not avail-
able for four subjects. 
Causes of Allograft Failure: The major causes for graft 
failure in the PBC patients and those transplanted for 
other indications were quite similar, except for an appar-
ent increase in hepatic vascular injury present in the 
patients transplanted for a condition other than PBC 
and a relative increase in the frequency of chronic rejec-
tion patients transplanted for PBC. Although a trend for 
these two differences between the two groups was noted, 
neither finding reached the level of being statistically 
significant (Table 2). All of the PBC patients who ex-
perienced graft loss because of chronic rejection did so 
less than 3 years after the date of transplantation. 
Graft and Patient Survival: There were no significant 
differences in the graft or patient survival of patients 
transplanted for PBC when compared to patients 
undergoing engraftment for all other indications. In fact, 
posttransplant patient survival for those with PBC was 
slightly better than for patients transplanted for other 
disorders (13). This was due to the inclusion of recipients 
with hepatitis B and hepatic malignancies, who have a 
high incidence of recurrent disease with an adverse 
outcome. 
Pathologic Comparison of Native Hepatectomies with 
PBC and Failed Allografts with Chronic Rejection 
Gross Pathology: The vast majority of native hepa-
tectomy specimens with PBC were enlarged (average = 
2,128 ± 380 gm), bile stained and cirrhotic. Enlarged 
hilar lymph nodes (up to 3.0 cm diameter) were often 
present. Focal atherosclerotic changes in the larger ar-
teries were occasionally present. Sectioning revealed a 
well-developed cirrhosis with regenerative nodules. 
In contrast, liver grafts removed for chronic rejection, 
while often enlarged (average in PBC patients = 1,816 ± 
481 gm and in non-PBC patients = 1,551 ± 370 gm), 
seldom if ever demonstrated nodularity (Figure 1). More-
over, dissection of the hepatic arterial system often re-
vealed thickened arterial walls with focal occlusion. 
Inflammation: The intensity of the portal/septal in-
flammation in chronic rejection specimens was usually 
mild (no. mild = 18, 82%; no. moderate = 1, 4%; no. 
severe = 3, 14%). The composition of the portal/septal 
infiltrate in both PBC and chronic rejection consisted 
largely of lymphocytes, macrophages and plasma cells. 
Periductal or intralobular granulomas with granuloma-
tous duct lesions were present in 25 (24%) of the native 
PBC livers but were not a feature of the chronic rejection 
specimens (no. = 0). Foamy cells could be seen around 
damaged intermediate-sized ducts in chronic rejection. 
Moreover, neutrophils were frequently present at the 
periphery of the nodules in areas of ongoing biliary and 
ductular type piecemeal necrosis in PBC specimens but 
were not prominent in cases of chronic rejection. Mono-
nuclear inflammation in and around the central veins 
and central venous sclerosis was present in 12 (55%) of· 
the chronically rejected livers but was not seen in any of 
the PBC livers. 
Bile Duct Changes: The small and intermediate-sized 
bile ducts were targets of the lymphocytic infiltration in 
both PBC and chronic liver allograft rejection, which 
presumably leads to bile duct damage, destruction and 
ultimately an apparent loss of bile ducts. Intermediate-
sized ducts appeared to be the preferred targets in early 
PBC. In contrast, the smallest ducts and ductules were 
the preferred targets in acute and chronic rejection. 
Degenerative changes were seen in the biliary epithelium 
in both disorders and included cytoplasmic eosinophilia, 
vacuolization, syncytia formation, pyknosis and disrup-
tion of the basement membrane. Additional evidence of 
bile duct damage includes reactive changes in the epithe-
lial cells such as enlargement, an increase in the nuclear I 
cytoplasmic ratio, stratification of the cells and the pres-
ence of nucleoli and mitosis (Figure 2). 
TABLE 2. Cause of graft failure by primary disease 
PBC (106 Non-PBC x2 (288 patients) Primary disease patients) No. No. (%) of probability (%) of grafts grafts (p value) 
Primary nonfunction a 5 (16) 11 (15) 0.89 
Vascular compromise b 10 (32) 31 (42) 0.48 
Acute rejection 4 (13) 11 (15) 0.97 
Chronic rejection 10' (32) 12d (16) 0.11 
Other' 2 (6) 9 (12) 0.6 
Total 31 (100) 74 (100) 
a Includes preservation injury and antibody-mediated rejection. The vascular tree was patent. 
b Includes hepatic artery or portal vein thrombosis, vascular wall dissections and antibody-mediated rejection. 
,. Ten grafts from nine patients (average graft survival 247 ± 302 days). 
d Twelve grafts from 10 patients (average graft survival 717 ± 843 days). 
e Includes biliary tract problems, recurrent disease and intrahepatic abscesses. 
Total (394 
patients) No. 
(%) of grafts 
16 (15) 
41 (39) 
15 (14) 
22 (21) 
11 (10) 
105 (100) 
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Fig. 1. Gross pathology. The gross ap-
pearance of a native liver with PBe (A) 
is different from an allograft failing from 
chronic rejection (B). Note the well-de-
veloped cirrhosis with capsular and re-
generative nodularity in (A) and its ab-
sence in (B). 
The portal inflammation present in PBC cases insid-
iously extended into the lobule to involve the periportal 
hepatic parenchyma in stage II (4) (or greater) disease, 
whereas in chronic rejection, the periportal involvement 
was considerably less and appeared to be more of a 
"spillover" phenomenon, but nonetheless could be clas-
sified loosely as being a form of lymphocytic piecemeal 
necrosis. 
Structures which were targets of the cellular immune 
attack in allograft rejection other than bile ducts but not 
seen in PBC included hilar nerve trunks and the hepatic 
arterial and portal as well as hepatic venous systems 
(Figure 3). 
Vascular Pathology: A lymphocytic subendothelial 
mononuclear cell infiltration of veins (portal and/or cen-
tral) was present and characteristic of acute rejection 
(40%). A similar lesion was not seen in either the chronic 
rejection specimens or in the PBC specimens. Hepatic 
venular sclerosis with surrounding inflammation was 
present in 12 (55%) of the chronically rejected livers 
(Figure 3). The venous pathology present in native PBC 
livers appeared to be limited to the portal venous system 
and consisted of thrombi which were at various stages of 
organization. 
A spectrum of arterial lesions was observed in chronic 
rejection specimens. These changes were present in 
nearly all of the chronically rejected allografts (no. = 21, 
95%) and included: a deposition of subintimal foam cells 
(most common); a mild lymphocytic and/or neutrophilic 
arteritis; myointimal hyperplasia and intimal sclerosis 
(Figure 3). All of the arterial lesions described in allograft 
livers can be found in association with immunoglobulin 
and complement deposition (15). Subintimal foam cells 
were seen occasionally in venous channels and around 
bile ducts in failed allografts. 
These arterial lesions were not a feature of PBC. 
However, a mild to moderate intimal sclerosis was often 
observed in hilar arterial vessels of native livers removed 
for PBC. Small and medium-sized arteries present in the 
fibrous septae of cirrhotic PBC specimens demonstrated 
focal medial thickening and an intimal sclerosis involv-
ing only a partial circumference of the vessel. Two PBC 
cases showed a focal necrotizing arteritis. Subintimal 
foam cells were not found in any PBC cases. 
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FIG. 2. Bile duct lesions. Both the intermediate- and small-sized bile ducts are the targets of putative lymphocytic mediated damage in PBC 
and allograft rejection. Note the similar appearance of the intermediate-sized duct lesions (except for the granulomatous reaction) in a 
pretransplant wedge biopsy from a PBC patient (A, H&E, 150x) and that seen posttransplantation in a failed allograft with chronic rejection 
(B, H&E, 150x). The smaller ducts are also targeted in both disorders, although somewhat more noticeably in allograft rejection (C, H&E, 
450X) . However, whereas prominent ductular proliferation is a hallmark of Stage 2 PBC (D, H&E, 400X), it is not a feature of allograft rejection. 
Parenchymal Changes: Reflective of their gross ap-
pearance, the majority (no. = 101, 95%) of native hepa-
tectomy specimens removed from patients with PBC 
displayed a well-developed cirrhosis. In contrast, well-
developed cirrhosis was not detected in any of the failed 
allografts in which rejection was the only cause of graft 
failure or in any of the allografts removed from a patient 
having had PBC. Two failed allografts removed from 
patients transplanted for a condition other than PBC 
were cirrhotic. The processes separate from or in addition 
to rejection which were thought to contribute to the 
development of cirrhosis in these two cases were viral 
liver disease (type B) and "autoimmune" hepatitis. 
The appearance of the periportal region of chronic 
rejection and PBC differed importantly (Figure 4). In 
general, there was an irregular margin between the portal 
tract/septae and the lobule in PBC, whereas in chronic 
rejection the limiting plate was either nonbreached or 
had a "moth-eaten" appearance (19 cases; 87%). The 
irregular margin in PBC was the result of a typical 
"piecemeal necrosis," which included all four types (lym-
phocytic, biliary, ductular and fibrotic) seen in classic 
cases of PBC (16, 17). All but six (94%) of the native 
PBC livers demonstrated a mixture of the biliary and 
fibrotic types of piecemeal necrosis. The native PBC 
livers with a predominant lymphocytic and ductular type 
of piecemeal necrosis were judged to be in Stage 2 to 3 
or 3. The periportal hepatocellular damage seen in 
chronic rejection (no. = 3, 13%) did not particularly fit 
the typical appearance of any particular type of piece-
meal necrosis but most closely resembled the lympho-
cytic type (Figure 4). Biliary, ductular and fibrotic types 
were not evident in livers with chronic rejection. 
Marginal ductular proliferation, a hallmark of the 
second stage of PBC (Figure 2), was not a prominent 
feature of chronic rejection, even in the face of extensive 
ductular damage and loss. 
Other histologic differences between advanced PBC 
and chronic rejection seen in the periportal region in-
clude the presence of a "clearing" between the portal 
tract/septae and the lobule, hyalin (no. = 21, 20%) and 
copper-associated protein deposits (no. = 23/25, 93%) in 
periportal hepatocytes and chole/cholate-stasis (no. = 
101,96%), all of which were seen in the PBC specimens 
but were absent in all of the cases of chronic rejection. 
Cholestasis was always seen at the endstage of both 
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FIG. 3. Pathologic features of rejection, not seen in PBC, include chronic obliterative arteriopathy (A, H&E, 150x), associated with large bile 
duct damage such as mural necrosis, epithelial sloughing and acute cholangitis (B, H&E, 40X). Subendothelial infiltration of portal (C, arrow, 
H&E, 150X) and/or central veins, centrilobular ballooning, atrophy or necrosis with sclerosis and cholestasis (D, CV = central vein, H&E, lOOx) 
and mononuclear cell infiltration of hilar nerve trunks (E, H&E, 100x) are features of rejection but not of PBC. 
disorders, but consistently differed in its location. The 
cholestasis associated with rejection, whether in the 
acute or chronic stage, was always predominantly cen-
trilobular whereas the cholestasis seen in PBC was most 
prominent periportally and spilled over toward the center 
of regenerative nodules. Copper-associated protein dep-
osition was not a prominent feature of chronic rejection 
but was consistently seen in advanced PBC. 
Lobular alterations present in both disorders included 
small clusters of sinusoidal foam cells, a mild spotty 
hepatocellular necrosis and slight Kupffer cell activation. 
Hilar structures, including the major bile ducts, were 
largely unaffected in PBC. In contrast, focal mural ne-
crosis, fibrosis, lymphocytic epithelial infiltration, epi-
thelial sloughing and acute cholangitis (Figure 3) were 
seen in large hilar bile ducts either as a consequence or 
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FtG . 4. Differences in the periportal regions. Reflective of their gross appearance, the majority of the native PBC specimens were cirrhotic 
(Stage 4) (A, H&E, 40x) , presumably as a result of the ongoing activity at the edge of the limiting plate (B, H&E, 400x). This in contrast to 
chronic rejection (C, H&E, 40x ) where there was a lack of a well-developed cirrhosis and most often only a mild residual portal infiltrate (D, PT 
= portal tract, H & E, 150X). E ven when the residual portal infiltrate was more intense (E, arrow, H&E, 150x), destruction of periportal 
hepatocytes was not a prominent feature. 
in association with rejection (no. = 6, 27%). Some of the 
large bile duct lesions seen in chronic rejection were 
clearly the result of coexistent arterial pathology which 
was present in the cases of rejection but not in PBC. 
Bilar Lymph Nodes: Enlarged hilar lymph nodes (up 
to 3 cm) were commonly seen in acutely rejecting livers 
and in endstage PBC. The nodes from 52 livers removed 
for PBC were available for examination. Twelve (23%) 
of these contained granulomas (nonlipid), two of which 
were necrotizing (4%). Eosinophilic histiocytic cells in 
the cortex and paracortex, atrophic "burnt out" germinal 
centers and sinusoids filled with pigmented macrophages 
(no. = 51, 94%) were common features in these nodes. 
None of these features were seen in the hilar nodes from 
livers that were acutely rejected except for the relative 
lack of germinal center formation and an occasional 
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poorly formed granuloma associated with infective or-
ganisms. The histologic features of nodes from acutely 
and chronically rejecting allografts consist of changes 
similar to those described for graft vs. host (11). 
A summary of the histologic' comparison of acute and 
chronic rejection to PBC is shown in Table 3. 
DISCUSSION 
We were unable to find a difference in the incidence 
or pathologic appearance of histologically documented 
episodes of acute cellular rejection between patients 
transplanted for PBC and those grafted for other indi-
cations. Nor was patient or graft survival affected by the 
presence of PBC prior to transplantation. We did, how-
ever, note a trend toward an increased incidence of 
allograft loss because of chronic rejection in PBC pa-
tients as compared to those who did not have this dis-
order. In addition, we were unable to diagnose recurrent 
PBC after transplantation. 
The argument could be made that our observation of 
a higher incidence of graft failure because of chronic 
rejection and lack of confirmation of recurrent PBC was 
the result of a mistaken histopathologic interpretation. 
This argument becomes even more appealing if one con-
jectures that recurrent disease in an allograft might be 
different histopathologically since the patients were re-
ceiving potent immunosuppressive therapy. Although we 
have been unable to recognize recurrent disease in the 
allograft, the data presented do not offer definitive proof 
that PBC cannot recur after transplantation. We can 
only state that we were unable to diagnose the disease 
using the criteria offered by Neuberger et a1. (10). The 
reasons we were unable to diagnose recurrent disease 
with certainty included the different histopathologic ap-
pearance of PBC and chronic rejection, the lack of cor-
relation of AMA levels with liver dysfunction and/or 
hepatic pathology and our ignorance of the effect of 
cyclosporin therapy on the histopathology of PBC. 
TABLE 3. Histopathologic comparison of PBe and liver 
allograft rejection 
Acute Early Chronic Late 
rejection PBC rejection PBC 
Portal/septal inflammation 
Intensity +++ +++ + ++ 
Nature" L, but mixed L,G,P L,P L,P,G 
Bile duct lesion 
Presence ++ ++ +++ + 
Size b S,M,L M,S S,M,L M,S 
Bile duct loss 0 0 +++ +++ 
Piecemeal necrosis ± ± ± ++ 
Cholangiolar proliferation ± ++ + 
Cholestasis' C C P,C 
With copper deposition None None None +++ 
Arterial lesions d Inflammatory or None SIFC, T IS 
necrotizing 
Venous lesions' SEL None SIFC, CVS PVT 
a Nature of inflammation: L = lymphocytic/monocytic; G = granulomatous; 
P = plasmacytic. 
b S = small «50 I'm); M = medium (;;,;75 I'm); L = hilar excretory ducts. 
Listed in order of prevalence. 
C Location of cholestasis: C = central; P = peripheral/parasepta1. 
d SIFC = subintimal foam cells; IS = intimal sclerosis; T = thrombosis . 
• SEL = subendothelial lymphocytes; CVS = central vein sclerosis; PVT = 
portal vein thrombi. 
One of the most striking histopathologic differences 
between PBC and chronic rejection is the nature and 
extent of the vascular pathology. Immune mechanisms 
probably account for the arterial lesions of rejection, 
which were not prominent in PBC. However, altered 
hemodynamics, infections and possibly altered lipid me-
tabolism may also playa role. Altered lipid metabolism 
and hemodynamics may account for the mild arterioscle-
rotic changes observed in PBC livers. Nevertheless, it 
must be stated clearly that the arterial changes seen in 
PBC are quite mild when compared to those seen in 
rejection. . . 
The architectural consequences of the putative Im-
mune damage, particularly in the periportal regions, and 
the size of damaged bile ducts (see "Results") also differs 
between these two disorders. This probably accounts for 
the frequent development of cirrhosis in PBC and its 
relative infrequency in chronic rejection. The reason for 
this difference is unclear at present. It may be due to an 
intrinsic difference in antigenic targets, alterations in 
the host immune system after transplantation because 
of obligatory immunosuppressive therapy or surgical in-
terventions prior to the development of cirrhosis. 
The differences in the histopathologic appearance of 
chronic rejection and PBC are probably related to the 
putative targets of immunologic attack in each disorder. 
The targets of the lymphocytic attack occurring as 
part of the rejection reaction in any solid organ allograft 
are thought to be the major histocompatibility complex 
antigens which are expressed on structures targeted by 
the rejection reaction (8,9). Functional a~alysis of.graft-
infiltrating lymphocytes cultured from lIver spKecfm~ns 
during a rejection reaction have confirmed prolIferative 
and cytotoxic activity directed at these antigens (18). 
The precise antigenic target(s) in PBC ha~ yet.to be 
precisely defined, but several reports have fmpl~ca~ed 
biliary glycoproteins (19-22). However, the speCIfiCIty 
and role of these antigens or even the effector mecha-
nisms involved in the liver damage in PBC are poorly 
understood. 
The serologic data presented indicate that there is 
either recurrence or failure to lose AMA, following trans-
plantation in the vast majority of PBC patients. The 
presence of elevated postoperative AMA. titers was ~llt 
associated with any evidence of hepatic dysfunctIOn 
which could be detected by utilizing standard liver injury 
parameters to monitor hepatic function in. ei~her this 
series (13) or that of Haagsma et a1. (23). SImIlarly, no 
apparent correlation between the AMA titers and pres-
ence of chronic rejection was seen in this study. There-
fore, the precise role of these antibodies in the pathogen-
esis of PBC is quite unclear. . 
The postoperative clinical course appears to be a clm-
ical criterion for distinguishing between the recurrent 
PBC and allograft rejection in that rejection tend~ ~o 
pursue an accelerated course while recurrent PBC, If It 
occurs at all appears to progress indolently (10). Based 
, ..
on this the livers removed from the patients m our senes 
who w~re originally transplanted for PBC most likely 
experienced rejection rather than recurrent PBC as all 
of the allografts failed within 3 years of the date of the 
------------- --
------------------------------------
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transplant procedure (Table 2). The validity of this par-
ticular criterion must be questioned, however, because 
patients whose original disease was not PBC can expe-
rience progressive dysfunction and graft failure with bile 
duct loss over a period of time which is reported to be 
more consistent with recurrent PBC (5 to 6 years). 
There are numerous possible explanations for the in-
creased incidence of chronic rejection in PBC patients, 
including patient age, sex, individual variations of im-
munosuppressive therapy, etc. These factors were not 
taken into consideration. A highly speculative conjecture 
for this perceived difference may be that a PBC patient's 
immune system may be specifically (i.e. against biliary 
antigens) or nonspecifically "sensitized." In this sense, 
the unique immunologic milieu of patients with PBC 
may be a contributory factor in the postoperative course. 
Perhaps mechanisms other than, or in addition to, an 
immune response directed at incompatible major histo-
compatibility complex antigens is occurring in patients 
transplanted for PBC. 
Despite the apparent pathologic differences between 
chronic rejection and PBC, a clear separation of these 
two disease processes may be made difficult as a result 
of the cyclosporin therapy. The difficulty of using path-
ologic observations for the diagnosis of PBC after trans-
plantation is underscored by the experience at Cam-
bridge (10). Since their original report, the Cambridge 
group has identified patients who developed a PBC-like 
syndrome (clinically and pathologically) after transplan-
tation but did not have the disease originally, nor did 
they convert to AMA positivity (24). Until the genesis of 
PBC (including the role of AMA) and the effect of 
cyclosporin therapy on PBC histology are better under-
stood, we may be forced to wait for more definitive 
disease markers to determine if PBC recurs or not. 
Although this series is rather large in comparison to 
others, it should be remembered that the number of 
posttransplant biopsies taken later than 3 years post-
transplant in our study is limited. In addition, because 
our patients have been maintained on cyclosporin 
whereas those reported by the Cambridge group having 
recurrent disease received azathioprine and not cyclo-
sporin, it may be impossible to reconcile the pathologic 
findings ofthe two groups. Finally, no number of negative 
cases can prove that PBC or any other disorder cannot 
recur; only one classic case needs to be documented to 
prove otherwise (10). Differences in the postoperative 
course of patients transplanted for PBC have been seen 
compared to those transplanted for other disorders. How-
ever, these differences have not affected the early «4 
years) graft or patient survival in the majority of patients 
transplanted for PBC. This is opposed to disorders such 
as viral hepatitis B (25) or certain hepatic malignancies 
(26) in which recurrent disease is more easily proven and 
affects both graft and patient survival. 
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